PHIP and hereditary clear cell renal cell carcinoma: In summary, this study firstly demonstrated that PhIP is a risk factor to induce osteoclastogenic activity and metastatic potential in human 786-O renal cell carcinoma cell line, while 6-Shogaol treatment reverses the PhIP-induced effect.